0.6755
price down icon3.50%   -0.0245
after-market After Hours: .68 0.0045 +0.67%
loading
Pavmed Inc stock is traded at $0.6755, with a volume of 132.22K. It is down -3.50% in the last 24 hours and down -8.72% over the past month. PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$0.70
Open:
$0.6852
24h Volume:
132.22K
Relative Volume:
0.71
Market Cap:
$11.52M
Revenue:
$4.03M
Net Income/Loss:
$24.32M
P/E Ratio:
-0.1571
EPS:
-4.3008
Net Cash Flow:
$-45.76M
1W Performance:
-17.12%
1M Performance:
-8.72%
6M Performance:
-45.96%
1Y Performance:
-66.89%
1-Day Range:
Value
$0.668
$0.7098
1-Week Range:
Value
$0.668
$0.8128
52-Week Range:
Value
$0.5719
$2.43

Pavmed Inc Stock (PAVM) Company Profile

Name
Name
Pavmed Inc
Name
Phone
(212) 949-4319
Name
Address
360 MADISON AVENUE, NEW YORK, NY
Name
Employee
107
Name
Twitter
@PAVmedinc
Name
Next Earnings Date
2024-11-13
Name
Latest SEC Filings
Name
PAVM's Discussions on Twitter

Compare PAVM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
PAVM
Pavmed Inc
0.6755 11.52M 4.03M 24.32M -45.76M -4.3008
Medical Devices icon
ABT
Abbott Laboratories
131.93 228.81B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.05 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
377.46 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.86 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.05 42.10B 5.72B 4.17B 259.90M 6.97

Pavmed Inc Stock (PAVM) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-30-21 Initiated Cantor Fitzgerald Overweight
Nov-05-20 Initiated Ascendiant Capital Markets Buy
Jun-28-18 Initiated Maxim Group Buy

Pavmed Inc Stock (PAVM) Latest News

pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

PAVmed outlines strategic milestones for 2025, including Veris implantable device submission - MSN

Mar 31, 2025
pulisher
Mar 30, 2025

Pavmed’s Strategic Growth and Financial Challenges - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

PAVmed Inc. (NASDAQ:PAVM) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025
pulisher
Mar 27, 2025

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - Nasdaq

Mar 27, 2025
pulisher
Mar 26, 2025

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability - Yahoo

Mar 26, 2025
pulisher
Mar 26, 2025

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com

Mar 26, 2025
pulisher
Mar 26, 2025

PAVmed Reports Strong Q4 Results and Strategic Progress - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

Earnings call transcript: PAVmed Q4 2024 reports net income boost - Investing.com India

Mar 25, 2025
pulisher
Mar 25, 2025

Earnings call transcript: PAVmed Q4 2024 reports net income boost By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

PAVmed Inc Surpasses Q4 2024 Revenue Estimates with $1.2 Million, Driven by Record EsoGuard Test Volume - GuruFocus

Mar 25, 2025
pulisher
Mar 25, 2025

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Placera.se

Mar 25, 2025
pulisher
Mar 25, 2025

PAVmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

PAVmed Achieves Triple Win: Record Tests, Insurance Coverage, Positive Income - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

Lucid Diagnostics Reports Strong Growth and Future Plans - TipRanks

Mar 25, 2025
pulisher
Mar 24, 2025

Lucid Diagnostics Achieves 84% Growth: EsoGuard Tests Hit All-Time High as Insurance Coverage Expands - Stock Titan

Mar 24, 2025
pulisher
Mar 20, 2025

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening - The Malaysian Reserve

Mar 20, 2025
pulisher
Mar 20, 2025

Lucid Diagnostics Announces Updated National Comprehensive Cance - GuruFocus

Mar 20, 2025
pulisher
Mar 20, 2025

Major Breakthrough: NCCN Backs New Esophageal Cancer Testing Method, Insurance Coverage Expected to Expand - Stock Titan

Mar 20, 2025
pulisher
Mar 19, 2025

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - BioSpace

Mar 19, 2025
pulisher
Mar 18, 2025

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Clinical Study: New EsoGuard Test Detects Esophageal Cancer Risk 140% More Effectively - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test - The Malaysian Reserve

Mar 13, 2025
pulisher
Mar 13, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test – Company AnnouncementFT.com - Financial Times

Mar 13, 2025
pulisher
Mar 13, 2025

Major Breakthrough: Lucid Diagnostics Secures Game-Changing Insurance Coverage for Cancer Test - Stock Titan

Mar 13, 2025
pulisher
Mar 11, 2025

Lucid Diagnostics Executes First Concierge Medicine Contract wit - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Pri - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025 - Longview News-Journal

Mar 11, 2025
pulisher
Mar 11, 2025

PAVmed CEO to Reveal Growth Strategy and Q4 Results in Upcoming Investor Call - Stock Titan

Mar 11, 2025
pulisher
Mar 10, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 - BioSpace

Mar 10, 2025
pulisher
Mar 07, 2025

Midtown company tells investors esophageal pre-cancer screening should be an easier pill to swallow - Crain's New York Business

Mar 07, 2025
pulisher
Mar 06, 2025

PAVmed, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering - BioSpace

Mar 06, 2025
pulisher
Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock offering By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock offering - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock sale By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering - The Eastern Progress Online

Mar 05, 2025
pulisher
Mar 05, 2025

SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow

Mar 05, 2025
pulisher
Mar 05, 2025

Insulet (NASDAQ:PODD) & PAVmed (NASDAQ:PAVM) Head-To-Head Review - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus.com

Mar 04, 2025
pulisher
Mar 04, 2025

Lucid Diagnostics ends "at the market" equity offering By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Lucid Diagnostics ends "at the market" equity offering - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Lucid Diagnostics secures $15.3 million in stock sale - Investing.com

Mar 04, 2025
pulisher
Mar 03, 2025

PAVmed Inc. (NASDAQ:PAVM) Short Interest Update - Defense World

Mar 03, 2025
pulisher
Feb 28, 2025

Tasso Partners Reports 18.9% Passive Stake In PAVmed As Of Feb 21SEC Filing - Marketscreener.com

Feb 28, 2025
pulisher
Feb 27, 2025

Can Lucid's Cancer Test Reach Millions More Patients? NIH Invests $8M to Find Out - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Lucid Diagnostics meets Nasdaq minimum bid price rule By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 25, 2025

Lucid Diagnostics Restores Nasdaq Listing Compliance - Nasdaq

Feb 25, 2025

Pavmed Inc Stock (PAVM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices STE
$227.57
price up icon 0.82%
medical_devices ZBH
$112.50
price up icon 0.12%
medical_devices PHG
$24.84
price down icon 1.55%
$68.14
price up icon 1.22%
$79.36
price down icon 0.26%
medical_devices EW
$72.05
price up icon 0.25%
Cap:     |  Volume (24h):